Vimarsana
Biggest News Aggregation in the World

Transcriptome Analysis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Transcriptome Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Transcriptome Analysis Today - Breaking & Trending Today

Milkfish fry research to aid in boosting supply, quality |  Rizza B. Ramoran - Vimarsana News

Milkfish fry research to aid in boosting supply, quality |  Rizza B. Ramoran

The milkfish fry in the Philippines is currently suffering from insufficient supply caused by high importation rate and low survival of hatchery-produced fry. But milkfish, or “bangus,” farmers no longer have to worry. Researches from the University of the Philippines Visayas (UPV) are targeting to address these concerns. Milkfish is…

Brucellosis - Symptoms and Signs, Diagnosis, Treatment, Prevention - Vimarsana News

Brucellosis - Symptoms and Signs, Diagnosis, Treatment, Prevention

Brucellosis is a contagious disease caused by Brucella. It is usually acquired following contact with an infected animal or animal products.

Frontiers | Tilapia Lake Virus-Induced Neuroinflammation in Zebrafish: Microglia Activation and Sickness Behavior - Vimarsana News

Frontiers | Tilapia Lake Virus-Induced Neuroinflammation in Zebrafish: Microglia Activation and Sickness Behavior

In mammals, the relationship between the immune system and behavior is widely studied. In fish, however, the knowledge concerning the brain immune response and behavioral changes during brain viral infection is very limited. To further investigate this subject, we used the model of tilapia lake virus (TiLV) infection of zebrafish (Danio rerio), which was previously developed in our laboratory. We demonstrated that TiLV persists in the brain of adult zebrafish for at least 90 days, even when the virus is not detectable in other peripheral organs. The virions were found in the whole brain. Durin...

Agendia Presents Data from Innovative FLEX Study at ASCO 2021 Showing MammaPrint and BluePrint Utility in Wide Variety of Patient Populations - Vimarsana News

Agendia Presents Data from Innovative FLEX Study at ASCO 2021 Showing MammaPrint and BluePrint Utility in Wide Variety of Patient Populations

Agendia, Inc., a world leader in precision oncology for breast cancer, announced that new data from the first-of-its kind, national FLEX registry was debuted today at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting.